Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate vs. Risedronate for Osteoporosis in Postmenopausal Women
NCT00092040Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of alendronate in postmenopausal osteoporosis, sponsored by Organon & Co.. Started Mar 2003; status: completed.
02
Drugs
alendronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00092040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092040.